Literature DB >> 30687061

CD30-Positive Angioinvasive Lymphomatoid Papulosis (Type E) Developing from Parapsoriasis en Plaque.

Taku Fujimura1, Chunbing Lyu1, Kenichiro Tsuchiyama1, Setsuya Aiba1.   

Abstract

Angioinvasive lymphomatoid papulosis (LyP) type E is a rare variant characterized by angiocentric and angiodestructive features with CD30+ CD8+ lymphocyte infiltration. In rare cases, LyP type E is concomitant with mycosis fungoides, but there is no English report that describe LyP type E developing from parapsoriasis en plaque. In this report, we described a case of angioinvasive LyP (type E) developing from parapsoriasis en plaque, in which we employed immunohistochemical staining for the investigation of its pathomechanisms.

Entities:  

Keywords:  Angioinvasive lymphomatoid papulosis; CCL17; CCR4; Granulysin; Parapsoriasis en plaque

Year:  2018        PMID: 30687061      PMCID: PMC6341360          DOI: 10.1159/000495689

Source DB:  PubMed          Journal:  Case Rep Oncol        ISSN: 1662-6575


Introduction

CD30+ lymphoproliferative disorders represent a spectrum of diseases, from lymphomatoid papulosis (LyP) to primary cutaneous anaplastic large cell lymphoma [1]. Among them, angioinvasive lymphomatoid papulosis (LyP) type E is a rare variant first described by Kempf in 2013, and characterized by angiocentric and angiodestructive features with small to medium sized lymphocytes that express CD30 and CD8 [2]. In rare cases, LyP type E occurs in patients with mycosis fungoides [3], but there is no English report describing LyP type E developing from parapsoriasis en plaque. In this report, we describe a case of angioinvasive LyP (type E) developing from parapsoriasis en plaque.

Case Report

A 76-year-old Japanese woman visited our outpatient clinic with an ulcerated, infiltrated plaque on the left side of the right leg. She had been treated for parapsoriasis en plaque with narrow band UVB irradiation for 4 years. On her initial visit, physical examination revealed an ulcerated, infiltrated plaque in the scaly erythema with atrophic lesions on the right lower legs (Fig. 1a). A biopsy specimen from the right lower leg revealed a dense perivascular infiltrate of atypical lymphoid in the upper dermis reaching into the subcutaneous tissue (Fig. 1b, c). Immunohistochemical staining revealed that these atypical lymphocytes, which were distributed throughout the dermis, were positive for CD3, CD8 (Fig. 2a), CD30 (Fig. 2b), granulysin (Fig. 2c) and CCR4 (Fig. 2d) and negative for CD4, CD7, and CD56. In addition, substantial numbers of CCL17 producing cells were detected at the center of the infiltrate (Fig. 2e), whereas CCL22 producing cells were not detected (data not shown). Therefore, we diagnosed angioinvasive LyP (typeE). We administered topical clobetasol propionate once a day for one month. The ulcerated, infiltrated plaque rapidly regressed within one month with a remaining scar, erythema, and skin atrophys (Fig. 2f).
Fig. 1

An ulcerated, infiltrated plaque on scaly erythema with skin atrophy on the right lower leg (a). Dense perivascular infiltrates of atypical lymphoid cells in the upper dermis reaching into the subcutaneous tissue (b, c). (H&E staining: Original magnification 50× [b], ×200 [c]).

Fig. 2

Immunohistochemistry and clinical follow up: anti-CD8 (a), anti-CD30 Ab (b), anti-granulysin Ab (c), anti-CCR4 Ab (d), and anti-CCL17 Ab (e). (Original magnification: ×200 [a–e]). The ulcerated, infiltrated plaque rapidly regressed within one month with a remaining scar, erythema, and skin atrophy (f).

Discussion

LyP is characterized by multiple papulonodular lesions that spontaneously regress within a few weeks [1]. One of the possible mechanisms for the spontaneous regression of LyP might be a subpopulation of myeloid cells that produce various chemokines and express immunomodulatory molecules such as PD-L1 [4], leading to the development of an immune reactive or immunosuppressive tumor microenvironment. In our present case, a dense infiltrate of CCL17 producing cells was observed at the center of the area with infiltrating atypical lymphocytes, which was surrounded by CCR4+CD8+CD30+ atypical lymphocytes. CCL17 is a chemokine produced by various dermal cells including tumor-associated macrophages (TAMs), dermal dendritic cells (DCs) and endothelial cells [5, 6]. CCL17 attracts CCR4+ lymphocytes, such as Th2 cells regulatory T cells and cutaneous T cell lymphoma (CTCL) cells [7]. Taken together, CCL17 producing cells might attract both CTCL cells and normal lymphocytes and may play a role in the development of the characteristic histological feature of angioinvasive LyP. As we described above, CCR4+ cells were not only CTCL cells but also normal lymphocytes. Interestingly, Kondo et al. reported that human CCR4+CD8+ immature memory T cells could produce multiple cytokines (IL-4, IFN-g, IL-2, TNFa) and migrate to inflammatory sites in the skin via CCR4/CCL17 pathways [8]. Notably, granulysin is expressed by NK cells and non-naive CD8+ T cells [9] that lyse various cancers including skin cancers [10]. Moreover, the expression of granulysin in the tumor microenvironment even co-relates with the prognosis of cancer patients [10]. In our present case, substantial numbers of granulysin-bearing cells co-existed with atypical lymphocytes in the lesional skin, which might play a role in the rapid clinical regression of the tumor. Since we present only a single case, further cases are needed to gain additional insight into the pathomechanisms of angioinvasive lymphomatoid papulosis.

Statement of Ethics

The patient gave written informed consent.

Disclosure Statement

The authors declare no conflict of interest.
  10 in total

1.  New variant lymphomatoid papulosis type E preceding and coexisting with mycosis fungoides - a case report and review of the literature.

Authors:  Katrin Kiavash; Sabra M Abner; Janine C Malone
Journal:  J Cutan Pathol       Date:  2015-09-03       Impact factor: 1.587

2.  Comparison of CD163+ Macrophages and CD206+ Cells in Lesional Skin of CD30+ Lymphoproliferative Disorders of Lymphomatoid Papulosis and Primary Cutaneous Anaplastic Large-cell Lymphoma.

Authors:  Aya Kakizaki; Taku Fujimura; Yumi Kambayashi; Sadanori Furudate; Mitsuko Kawano; Kouetsu Ogasawara; Setsuya Aiba
Journal:  Acta Derm Venereol       Date:  2015-05       Impact factor: 4.437

3.  Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways.

Authors:  T Fujimura; Y Kambayashi; S Furudate; A Kakizaki; T Hidaka; S Aiba
Journal:  Br J Dermatol       Date:  2016-12-22       Impact factor: 9.302

4.  Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas.

Authors:  Werner Kempf; Dmitry V Kazakov; Leo Schärer; Arno Rütten; Thomas Mentzel; Bruno E Paredes; Gabriele Palmedo; Renato G Panizzon; Heinz Kutzner
Journal:  Am J Surg Pathol       Date:  2013-01       Impact factor: 6.394

5.  Phospho-STAT5B Expression Is a Prognostic Marker for Merkel Cell Carcinoma.

Authors:  Taku Fujimura; Sadanori Furudate; Yumi Kambayahsi; Aya Kakizaki; Yuki Yamamoto; Hisako Okuhira; Noriki Fujimoto; Setsuya Aiba
Journal:  Anticancer Res       Date:  2017-05       Impact factor: 2.480

6.  Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns.

Authors:  Bertram Bengsch; Takuya Ohtani; Ramin Sedaghat Herati; Niels Bovenschen; Kyong-Mi Chang; E John Wherry
Journal:  J Immunol Methods       Date:  2017-03-19       Impact factor: 2.303

Review 7.  EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Authors:  Werner Kempf; Katrin Pfaltz; Maarten H Vermeer; Antonio Cozzio; Pablo L Ortiz-Romero; Martine Bagot; Elise Olsen; Youn H Kim; Reinhard Dummer; Nicola Pimpinelli; Sean Whittaker; Emmilia Hodak; Lorenzo Cerroni; Emilio Berti; Steve Horwitz; H Miles Prince; Joan Guitart; Teresa Estrach; José A Sanches; Madeleine Duvic; Annamari Ranki; Brigitte Dreno; Sonja Ostheeren-Michaelis; Robert Knobler; Gary Wood; Rein Willemze
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

8.  Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokines.

Authors:  Takaaki Kondo; Masafumi Takiguchi
Journal:  Int Immunol       Date:  2009-03-04       Impact factor: 4.823

9.  Expression of thymus and activation-regulated chemokine (TARC) by human dermal cells, but not epidermal keratinocytes.

Authors:  Tetsuo Shoda; Kyoko Futamura; Fumio Kobayashi; Hirohisa Saito; Kenji Matsumoto; Akio Matsuda
Journal:  J Dermatol Sci       Date:  2014-08-28       Impact factor: 4.563

Review 10.  Tumor microenvironment in mycosis fungoides and Sézary syndrome.

Authors:  Belen Rubio Gonzalez; Jasmine Zain; Steven T Rosen; Christiane Querfeld
Journal:  Curr Opin Oncol       Date:  2016-01       Impact factor: 3.645

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.